Results 141 to 150 of about 11,423 (215)

The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine
Background/Objectives: Minoxidil, in addition to its vasodilatory effect, has also immunomodulatory properties that may be partially responsible for its efficacy in alopecia areata.
Michal Ordak, Lidia Rudnicka, Anna Waskiel-Burnat   +2 more
exaly   +2 more sources

Minoxidil: a comprehensive review

Journal of dermatological treatment (Print), 2021
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/β-catenin ...
A. Gupta, M. Talukder, M. Venkataraman, M. Bamimore   +3 more
semanticscholar   +1 more source

Minoxidil

Annals of Internal Medicine, 1981
Minoxidil is an orally active vasodilator for treatment of severe hypertension. In combination with diuretics and beta-adrenergic blocking agents, it is effective treatment for more than 80% of patients whose blood pressure has been inadequately controlled with combinations of other been inadequately controlled with combinations of other ...
S L, Linas, A S, Nies
openaire   +2 more sources

Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia

Journal of dermatological treatment (Print), 2022
Background Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. While oral finasteride (1 mg/d) is an FDA-approved treatment for male AGA, oral minoxidil and oral dutasteride are not approved yet.
Aditya K. Gupta, M. Talukder, Greg Williams   +2 more
semanticscholar   +1 more source

Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model.

Acta Biomaterialia, 2022
Alopecia is defined as hair loss in a part of the head due to various causes, such as drugs, stress and autoimmune disorders. Various therapeutic agents have been suggested depending on the cause of the condition and patient sex, and age. Minoxidil (MXD)
Min Jae Kim, Keum-Yong Seong, Da Som Kim, Jea Sic Jeong, So Young Kim, Seungsoo Lee, S. Yang, B. An   +7 more
semanticscholar   +1 more source

Evaluation of Minoxidil

American Journal of Health-System Pharmacy, 1980
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex ...
D D, Miller, D W, Love
openaire   +2 more sources

Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review

Skin Appendage Disorders, 2023
Low-dose oral minoxidil (LDOM) has demonstrated a promising safety and efficacy profile in the treatment of various hair disorders, including male androgenetic alopecia (AGA) and female-pattern hair loss (FPHL); however, it lacks FDA approval.
Aditya K. Gupta, M. Talukder, Avner Shemar, B. Piraccini, A. Tosti   +4 more
semanticscholar   +1 more source

Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients.

Journal of American Academy of Dermatology, 2021
BACKGROUND The major concern regarding the use of low-dose oral minoxidil (LDOM) in the treatment of hair loss is the potential risk of systemic adverse effects.
S. Vañó‐Galván, R. Pirmez, Á. Hermosa-Gelbard, Ó. Moreno‐Arrones, D. Saceda‐Corralo, R. Rodrigues-Barata, J. Jimenez‐Cauhe, Wei Koh, J. Poa, R. Jerjen, Lara Trindade de Carvalho, J. John, C. I. Salas-Callo, C. Vincenzi, Lu Yin, Kristen Lo-Sicco, A. Waśkiel-Burnat, M. Starace, J. Zamorano, P. Jaén‐Olasolo, B. Piraccini, Lidia Rudnicka, Jerry Shapiro, A. Tosti, R. Sinclair, B. Bhoyrul   +25 more
semanticscholar   +1 more source